Alixia, Inc. — Form D
Alixia, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-23. The offering totals $3.5M, of which $1.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-07-23
- Form: D
- Accession: 0002031477-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.5M
- Amount sold: $1.8M
- Remaining: $1.6M
- Investors: 19
- Date of first sale: 2024-07-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-519525
Issuer
- Name: Alixia, Inc.
- CIK: 0002031477
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 953 INDIANA STREET, SAN FRANCISCO, CA, 94107
- Phone: 858-922-9965
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Helen Yee-Fang Chen | Director | San Francisco, CA |
| Sungwon Olof Lim | Director | San Francisco, CA |
| Lars Olof Mollstedt | Director | San Francisco, CA |
| Helen Yee-Fang Chen | Executive Officer | San Francisco, CA |
| Lars Olof Mollstedt | Executive Officer | San Francisco, CA |
More